Original articles
UPDATE ON ETIOPATHOGENESIS, RISK FACTORS
AND TREATMENT OF HIDRADENITIS SUPPURATIVA
Abstract: The prevalence of hidradenitis suppurativa
(HS) in general population ranges from 1% to 4%, while its
etiopathogenesis is still incompletely determined and
multifactorial. The management of these diseases is
complex, as the current therapy does not a curative role but
rather aims at reducing the chronic inflammation and
maintaining the remission state, by preventing the
worsening and progression of the disease